Trial Profile
The effect of combination therapy with Ezetimibe and Gemfibrozile on post-prandial hypertriglyceridemia in type 2 Diabetic patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2016
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Gemfibrozil (Primary) ; Atorvastatin
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- 09 May 2012 Status changed from recruiting to active, no longer recruiting as reported by Iranian Registry of Clinical Trials.
- 26 Sep 2011 New trial record